These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 19411568

  • 1. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
    Bolton CE, Stone MD, Edwards PH, Duckers JM, Evans WD, Shale DJ.
    Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
    [Abstract] [Full Text] [Related]

  • 2. [Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease].
    Kochetkova EA, Ugaĭ LG, Maĭstrovskaia IuV, Buria KA, Nevzorova VA.
    Ter Arkh; 2012; 84(8):37-40. PubMed ID: 22994087
    [Abstract] [Full Text] [Related]

  • 3. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF, Zhao M, Li ZL, Song Y, Shi Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M.
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
    Piesiak P, Brzecka A, Kosacka M, Passowicz-Muszyńska E, Dyła T, Jankowska R.
    Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
    [Abstract] [Full Text] [Related]

  • 9. Should COPD patients be routinely evaluated for bone mineral density?
    Karadag F, Cildag O, Yurekli Y, Gurgey O.
    J Bone Miner Metab; 2003 Nov; 21(4):242-6. PubMed ID: 12811630
    [Abstract] [Full Text] [Related]

  • 10. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT.
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [Abstract] [Full Text] [Related]

  • 11. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B, Batura-Gabryel H, Nowicka A, Kuznar-Kaminska B, Szczepanik A.
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [Abstract] [Full Text] [Related]

  • 12. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM, Sun TY, Lin JB, Zhang HS.
    Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1138-41. PubMed ID: 12921631
    [Abstract] [Full Text] [Related]

  • 13. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB, von Wachenfeldt KA, Larsson S, Mile I, Persdotter S, Dahlbäck M, Broberg P, Stoel B, Bach KS, Hestad M, Fehniger TE, Dirksen A.
    Clin Respir J; 2008 Jan 10; 2(1):17-25. PubMed ID: 20298300
    [Abstract] [Full Text] [Related]

  • 14. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM, Gerlach RF, Tanus-Santos JE.
    Clin Chim Acta; 2009 May 10; 403(1-2):173-7. PubMed ID: 19254704
    [Abstract] [Full Text] [Related]

  • 15. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
    Guo LJ, Luo XH, Wu XP, Xie H, Zhou HD, Zhang H, Cao XZ, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):734-7. PubMed ID: 15949377
    [Abstract] [Full Text] [Related]

  • 16. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
    Calikoğlu M, Unlü A, Tamer L, Ozgür E.
    Tuberk Toraks; 2006 Mar 23; 54(2):114-21. PubMed ID: 16924566
    [Abstract] [Full Text] [Related]

  • 17. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
    Marcaccini AM, Novaes AB, Meschiari CA, Souza SL, Palioto DB, Sorgi CA, Faccioli LH, Tanus-Santos JE, Gerlach RF.
    Clin Chim Acta; 2009 Nov 23; 409(1-2):117-22. PubMed ID: 19751716
    [Abstract] [Full Text] [Related]

  • 18. Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study.
    Kwiatkowska S, Noweta K, Zieba M, Nowak D, Bialasiewicz P.
    Respiration; 2012 Nov 23; 84(3):231-41. PubMed ID: 22832426
    [Abstract] [Full Text] [Related]

  • 19. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
    Higashimoto Y, Yamagata Y, Iwata T, Okada M, Ishiguchi T, Sato H, Masuda M, Itoh H.
    Eur Respir J; 2005 May 23; 25(5):885-90. PubMed ID: 15863647
    [Abstract] [Full Text] [Related]

  • 20. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF, Chin CH, Wang CC, Lin MC.
    Respirology; 2009 Sep 23; 14(7):999-1004. PubMed ID: 19740260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.